Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners（2022）
Abstract
A structured patient-centered pharmacy practice model integrating the ASCO/NCODA patient-centered standards and ongoing communication with patients and healthcare providers ensure timely refills, close monitoring, and allows patients to achieve high adherence and persistence rates comparable to those reported in clinical trials.
MoreTranslated text
Key words
CDK4/6 inhibitors,Oncology pharmacy practice,breast cancer,quality improvement,real-world evidence
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined